Arcellx (ACLX) had the best week in June 2022 by a mid-cap US stock the week of June 6, 2022, returning 83.7%.
| ASSET | WEEK | % RETURN |
|---|---|---|
Arcellx (ACLX) | 6/6/2022 - 6/12/2022 | 83.68% |
Belite Bio Inc ADR (BLTE) | 6/13/2022 - 6/19/2022 | 54.15% |
Akero Therapeutics (AKRO) | 6/13/2022 - 6/19/2022 | 47.39% |
Centessa Pharmaceuticals PLC ADR (CNTA) | 6/13/2022 - 6/19/2022 | 34.7% |
Miniso Group Holding (MNSO) | 6/13/2022 - 6/19/2022 | 34.09% |
Nuvalent (NUVL) | 6/20/2022 - 6/26/2022 | 32.07% |
Veracyte (VCYT) | 6/20/2022 - 6/26/2022 | 30.99% |
Appian (APPN) | 6/20/2022 - 6/26/2022 | 28.6% |
Denali Therapeutics (DNLI) | 6/20/2022 - 6/26/2022 | 26.14% |
Kymera Therapeutics (KYMR) | 6/20/2022 - 6/26/2022 | 24.95% |
Immunitybio (IBRX) | 6/20/2022 - 6/26/2022 | 24.92% |
Regencell Bioscience (RGC) | 5/30/2022 - 6/5/2022 | 24.59% |
Recursion Pharmaceuticals (RXRX) | 6/13/2022 - 6/19/2022 | 23.7% |
Liquidia Technologies (LQDA) | 6/13/2022 - 6/19/2022 | 23.04% |
Agios Pharm (AGIO) | 6/20/2022 - 6/26/2022 | 22.86% |
Confluent (CFLT) | 6/20/2022 - 6/26/2022 | 22.78% |
Global-E Online (GLBE) | 6/20/2022 - 6/26/2022 | 22.48% |
Monday (MNDY) | 6/20/2022 - 6/26/2022 | 22.38% |
BridgeBio Pharma (BBIO) | 6/13/2022 - 6/19/2022 | 22.2% |
Guardant Health (GH) | 6/20/2022 - 6/26/2022 | 22.19% |
Asana (ASAN) | 6/20/2022 - 6/26/2022 | 22.18% |
Belite Bio Inc ADR (BLTE) | 6/6/2022 - 6/12/2022 | 22.1% |
Dlocal (DLO) | 6/20/2022 - 6/26/2022 | 22.04% |
Sharplink Gaming (SBET) | 6/6/2022 - 6/12/2022 | 21.95% |
Jfrog (FROG) | 6/20/2022 - 6/26/2022 | 21.88% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
